Lopinavir/ritonavir treatment in HIV antiretroviral-experienced patients: evaluation of risk factors for liver enzyme elevation

HIV Medicine
P MeravigliaA Cargnel

Abstract

To evaluate the risk factors for lopinavir/ritonavir (LPV/r)-related liver enzyme elevation (LEE) in HIV antiretroviral-experienced patients. An open prospective observational study was carried out to analyse the incidence and time of LEE development during LPV/r treatment, and to determine whether LEE development was correlated with epidemiological, clinical and biochemical data, immune and virological profiles, concomitant hepatic diseases, antiretroviral therapy, or histological and ultrasonography liver examination results. A diagnosis of LEE was considered when LEE symptoms occurred after LPV/r introduction and was confirmed by a second control within 2 weeks. A total of 782 HIV-positive outpatients have been enrolled in six different Infectious Diseases Departments in Northern Italy since August 2000. Of these patients, 71 (9.1%) developed LEE within 115+/-85 days (mean+/-standard deviation); 13 of these subjects discontinued LPV/r and four were hospitalized. Of the patients with LEE, 74.6% and 25.4% had grade 2 and > or =3 toxicity, respectively. No correlation between LEE and sex, baseline CD4 cell count, viral load, HIV stage, triglyceride values, histological and ultrasonography liver examination results, nevirapine u...Continue Reading

References

Jun 1, 1995·Journal of Hepatology·K IshakR N MacSween
Jul 1, 1997·Journal of Hepatology·J OckengaR E Schmidt
Jul 11, 1998·JAMA : the Journal of the American Medical Association·W G PowderlyM M Lederman
Aug 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A Cerny, F V Chisari
Jan 13, 2000·American Journal of Clinical Pathology·K G Ishak
Feb 3, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H MarusawaT Chiba
Nov 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E H GisolfUNKNOWN Prometheus Study Group
Aug 2, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y BenhamouUNKNOWN MultivirC Group
Oct 9, 2001·International Journal of STD & AIDS·J Arribas
Jan 12, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mark S SulkowskiRichard D Moore
Apr 10, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Curtis L CooperJonathan B Angel
Jun 6, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Marina NúñezVincent Soriano
Jul 20, 2002·AIDS·Corinne RancinanUNKNOWN Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA)
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David L Thomas
Nov 1, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·F BonnetUNKNOWN French Aquitaine Cohort. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA)
Dec 7, 2002·Microbes and Infection·Mandana Khalili, Brian W Behm

❮ Previous
Next ❯

Citations

Jul 20, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A F T B GouveaR C M Succi
Jun 22, 2010·AIDS Research and Human Retroviruses·Keith W CrawfordUNKNOWN AIDS Clinical Trials Protocol 5015 Team
Dec 20, 2007·AIDS·Vincent SorianoBarbara McGovern
Dec 3, 2014·Clinics in Liver Disease·Chathur AcharyaRichard K Sterling
Apr 5, 2011·Hepatobiliary & Pancreatic Diseases International : HBPD INT·Jia-Jia ChenLan-Juan Li
Aug 29, 2007·Clinics in Liver Disease·Mamta K Jain
Oct 20, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yun WangHuiping Zhou
Apr 25, 2006·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·R BrunoG Filice
Dec 21, 2005·Journal of Hepatology·Marina Núñez
Sep 7, 2005·The Journal of Antimicrobial Chemotherapy·Elena SeminariAntonella Castagna
Jun 20, 2020·Journal of Medical Virology·Yang LiXuebing Yan
Jun 20, 2020·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Xiaojing ZouJiao Huang
Sep 16, 2020·European Journal of Pharmacology·Chuan-Feng TangLing-Dong Kong
Sep 18, 2021·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Joseph William ClintonJames H Lewis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.